Industry News
Pykus Therapeutics to Present Initial Clinical Data on Novel Retinal Sealant PYK-2101

Pykus Therapeutics has announced it will present initial clinical data on PYK-2101, an investigation...

read more
Pykus Therapeutics to Present Initial Clinical Data on Novel Retinal Sealant PYK-2101
February 07, 2025
Lumenis Launches OptiLIFT to Address Lower Lid Laxity and Impaired Blinking

Lumenis Be. Ltd., a global leader in energy-based medical devices for eye care and aesthetics, has a...

read more
Lumenis Launches OptiLIFT to Address Lower Lid Laxity and Impaired Blinking
February 07, 2025
EssilorLuxottica’s Nuance Audio Glasses: A Vision and Hearing Innovation Approved by FDA

EssilorLuxottica has received FDA medical device approval for its Nuance Audio Glasses, a groundbrea...

read more
EssilorLuxottica’s Nuance Audio Glasses: A Vision and Hearing Innovation Approved by FDA
February 06, 2025
Qlaris Bio Reports Positive Phase 2 Results for QLS-111 in Glaucoma and Ocular Hypertension

Qlaris Bio has announced positive topline results from two U.S. Phase 2 clinical trials—Osprey and A...

read more
Qlaris Bio Reports Positive Phase 2 Results for QLS-111 in Glaucoma and Ocular Hypertension
February 06, 2025
EyePoint Reports Positive 6-Month Results for Phase 2 VERONA Trial of Duravyu in DME

EyePoint Pharmaceuticals has announced positive 6-month results from its ongoing Phase 2 VERONA clin...

read more
EyePoint Reports Positive 6-Month Results for Phase 2 VERONA Trial of Duravyu in DME
February 06, 2025
McKesson Acquires Controlling Interest in PRISM Vision Holdings

McKesson Corporation has signed a definitive agreement to acquire an 80 percent controlling interest...

read more
McKesson Acquires Controlling Interest in PRISM Vision Holdings
February 05, 2025
Notal Vision Publishes Positive Results from Pivotal Study on AI Algorithm in Home-Based OCT System

Notal Vision has announced positive results from a pivotal study evaluating an artificial intelligen...

read more
Notal Vision Publishes Positive Results from Pivotal Study on AI Algorithm in Home-Based OCT System
February 04, 2025
Beacon Therapeutics Secures RMAT Designation for Laru-Zova Gene Therapy in XLRP Treatment

Beacon Therapeutics' laruparetigene zovaparvovec (laru-zova), a gene therapy for X-linked retinitis ...

read more
Beacon Therapeutics Secures RMAT Designation for Laru-Zova Gene Therapy in XLRP Treatment
February 03, 2025
Iantrek Announces First Commercial Cases of C.Rex Micro-Interventional System for Trabecular Outflow Enhancement

Iantrek has successfully completed the first commercial cases utilizing its C.Rex micro-intervention...

read more
Iantrek Announces First Commercial Cases of C.Rex Micro-Interventional System for Trabecular Outflow Enhancement
February 03, 2025
Vyluma Announces NMPA Acceptance of NVK002 for Pediatric Myopia in China

Vyluma has announced that the National Medical Products Administration (NMPA) of China has accepted ...

read more
Vyluma Announces NMPA Acceptance of NVK002 for Pediatric Myopia in China
January 31, 2025
More